131 related articles for article (PubMed ID: 15661019)
1. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation.
Orange JS; Levy O; Geha RS
Immunol Rev; 2005 Feb; 203():21-37. PubMed ID: 15661019
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the NF-kappaB signaling pathway: implications for human disease.
Courtois G; Gilmore TD
Oncogene; 2006 Oct; 25(51):6831-43. PubMed ID: 17072331
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB-related genetic diseases.
Courtois G; Smahi A
Cell Death Differ; 2006 May; 13(5):843-51. PubMed ID: 16397577
[TBL] [Abstract][Full Text] [Related]
4. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
Yates LL; Górecki DC
Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
[TBL] [Abstract][Full Text] [Related]
5. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
6. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
[TBL] [Abstract][Full Text] [Related]
7. Circuitry of nuclear factor kappaB signaling.
Hoffmann A; Baltimore D
Immunol Rev; 2006 Apr; 210():171-86. PubMed ID: 16623771
[TBL] [Abstract][Full Text] [Related]
8. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases.
Bustamante J; Boisson-Dupuis S; Jouanguy E; Picard C; Puel A; Abel L; Casanova JL
Curr Opin Immunol; 2008 Feb; 20(1):39-48. PubMed ID: 18083507
[TBL] [Abstract][Full Text] [Related]
9. Heritable defects of the human TLR signalling pathways.
Puel A; Yang K; Ku CL; von Bernuth H; Bustamante J; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
J Endotoxin Res; 2005; 11(4):220-4. PubMed ID: 16176658
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappaB activation: from bench to bedside.
Sethi G; Sung B; Aggarwal BB
Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
[TBL] [Abstract][Full Text] [Related]
11. Regulation of NF-kappaB transcriptional activity.
Vermeulen L; Vanden Berghe W; Haegeman G
Cancer Treat Res; 2006; 130():89-102. PubMed ID: 16610704
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
Perkins ND
Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
[TBL] [Abstract][Full Text] [Related]
13. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells.
Reuter S; Charlet J; Juncker T; Teiten MH; Dicato M; Diederich M
Ann N Y Acad Sci; 2009 Aug; 1171():436-47. PubMed ID: 19723087
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes.
Diatchenko L; Romanov S; Malinina I; Clarke J; Tchivilev I; Li X; Makarov SS
J Leukoc Biol; 2005 Dec; 78(6):1366-77. PubMed ID: 16204640
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
Egan LJ; Toruner M
Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
[TBL] [Abstract][Full Text] [Related]
17. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.
Liuzzo G; Santamaria M; Biasucci LM; Narducci M; Colafrancesco V; Porto A; Brugaletta S; Pinnelli M; Rizzello V; Maseri A; Crea F
J Am Coll Cardiol; 2007 Jan; 49(2):185-94. PubMed ID: 17222729
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
Sarkar FH; Li Y; Wang Z; Kong D
Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
[TBL] [Abstract][Full Text] [Related]
19. Activation of nuclear factor kappa B by different agents: influence of culture conditions in a cell-based assay.
Hellweg CE; Arenz A; Bogner S; Schmitz C; Baumstark-Khan C
Ann N Y Acad Sci; 2006 Dec; 1091():191-204. PubMed ID: 17341614
[TBL] [Abstract][Full Text] [Related]
20. Analysis of interleukin-1beta-modulated mRNA gene transcription in human gingival keratinocytes by epithelia-specific cDNA microarrays.
Steinberg T; Dannewitz B; Tomakidi P; Hoheisel JD; Müssig E; Kohl A; Nees M
J Periodontal Res; 2006 Oct; 41(5):426-46. PubMed ID: 16953820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]